Targeting matrix remodeling in cardiac hypertrophy and heart failure

Merry L. Lindsey; Francis G. Spinale

doi:10.1016/j.ddstr.2005.08.001

Targeting matrix remodeling in cardiac hypertrophy and heart failure

Merry L. Lindsey, Francis G. Spinale

Research output: Contribution to journal › Review article

2 Scopus citations

Abstract

Chronic pressure overload, such as that with hypertension, induces left ventricular (LV) remodeling characterized by increased mass, that is, LV hypertrophy (LVH). LVH can cause impaired diastolic function and thereby contribute to heart failure. The myocardial extracellular matrix undergoes significant remodeling in LVH contributing to abnormalities in diastolic function. Current pharmacological strategies for the treatment of hypertension only indirectly and/or incompletely affect the structure and composition of the myocardial matrix. Identifying crucial pathways involved in matrix remodeling in hypertension-induced LVH will aid in the selection of more relevant targets.

Original language	English (US)
Pages (from-to)	253-258
Number of pages	6
Journal	Drug Discovery Today: Therapeutic Strategies
Volume	2
Issue number	3
DOIs	https://doi.org/10.1016/j.ddstr.2005.08.001
State	Published - 2005

ASJC Scopus subject areas

Molecular Medicine
Pharmacology
Drug Discovery

Access to Document

10.1016/j.ddstr.2005.08.001

Fingerprint Dive into the research topics of 'Targeting matrix remodeling in cardiac hypertrophy and heart failure'. Together they form a unique fingerprint.

Cite this

Lindsey, M. L., & Spinale, F. G. (2005). Targeting matrix remodeling in cardiac hypertrophy and heart failure. Drug Discovery Today: Therapeutic Strategies, 2(3), 253-258. https://doi.org/10.1016/j.ddstr.2005.08.001

@article{765ace46bbcb42ce8b9d1ca10880bfa1,

title = "Targeting matrix remodeling in cardiac hypertrophy and heart failure",

abstract = "Chronic pressure overload, such as that with hypertension, induces left ventricular (LV) remodeling characterized by increased mass, that is, LV hypertrophy (LVH). LVH can cause impaired diastolic function and thereby contribute to heart failure. The myocardial extracellular matrix undergoes significant remodeling in LVH contributing to abnormalities in diastolic function. Current pharmacological strategies for the treatment of hypertension only indirectly and/or incompletely affect the structure and composition of the myocardial matrix. Identifying crucial pathways involved in matrix remodeling in hypertension-induced LVH will aid in the selection of more relevant targets.",

author = "Lindsey, {Merry L.} and Spinale, {Francis G.}",

year = "2005",

doi = "10.1016/j.ddstr.2005.08.001",

language = "English (US)",

volume = "2",

pages = "253--258",

journal = "Drug Discovery Today: Therapeutic Strategies",

issn = "1740-6773",

publisher = "Elsevier Limited",

number = "3",

}

TY - JOUR

T1 - Targeting matrix remodeling in cardiac hypertrophy and heart failure

AU - Lindsey, Merry L.

AU - Spinale, Francis G.

PY - 2005

Y1 - 2005

N2 - Chronic pressure overload, such as that with hypertension, induces left ventricular (LV) remodeling characterized by increased mass, that is, LV hypertrophy (LVH). LVH can cause impaired diastolic function and thereby contribute to heart failure. The myocardial extracellular matrix undergoes significant remodeling in LVH contributing to abnormalities in diastolic function. Current pharmacological strategies for the treatment of hypertension only indirectly and/or incompletely affect the structure and composition of the myocardial matrix. Identifying crucial pathways involved in matrix remodeling in hypertension-induced LVH will aid in the selection of more relevant targets.

AB - Chronic pressure overload, such as that with hypertension, induces left ventricular (LV) remodeling characterized by increased mass, that is, LV hypertrophy (LVH). LVH can cause impaired diastolic function and thereby contribute to heart failure. The myocardial extracellular matrix undergoes significant remodeling in LVH contributing to abnormalities in diastolic function. Current pharmacological strategies for the treatment of hypertension only indirectly and/or incompletely affect the structure and composition of the myocardial matrix. Identifying crucial pathways involved in matrix remodeling in hypertension-induced LVH will aid in the selection of more relevant targets.

UR - http://www.scopus.com/inward/record.url?scp=27144441381&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27144441381&partnerID=8YFLogxK

U2 - 10.1016/j.ddstr.2005.08.001

DO - 10.1016/j.ddstr.2005.08.001

M3 - Review article

AN - SCOPUS:27144441381

VL - 2

SP - 253

EP - 258

JO - Drug Discovery Today: Therapeutic Strategies

JF - Drug Discovery Today: Therapeutic Strategies

SN - 1740-6773

IS - 3

ER -